Trials Sponsors Conditions Drugs Pricing

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Sleep FragmentationQuality of LifeAir Filters

Outcome Measures

Primary Outcomes (1)

Change in Sleep Fragmentation Index from baseline
Data is obtained from a wrist-worn motion sensor that detects body movement. From these data, the number of disruptions during sleep can be calculated.
Measurements are averaged during the first week of the study (baseline) and then during week 2 and week 4 when subjects slept with the air purifier with either HEPA or SHAM filtration

Secondary Outcomes (1)

Change in Sleep-related quality of life from baseline
Measurements are taken at the start of the study (baseline) and then at the end of week 2 and week 4 when subjects slept with the air purifier with either HEPA or SHAM filtration

Study Arms (1)

Nocturnal Air Purification

EXPERIMENTAL

* Hepa Filtration with PureNight * SHAM with PureNight

Other: HEPA filtrationOther: SHAM

Interventions

HEPA filtrationOther

Night time air purification with the PureNight air purification system with the HEPA filter in place

Nocturnal Air Purification

SHAMOther

Night time air purification with the PureNight air purification system with the HEPA filter removed

Nocturnal Air Purification

Eligibility Criteria

Age35 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Diagnosis of COPD, chronic airway obstruction, chronic bronchitis or emphysema or \> 15 pack year history of tobacco use
Secondary diagnosis of extrinsic asthma or allergic rhinitis or \> 200 ml FEV1 response to bronchodilators documented on pulmonary function testing

Sponsors & Collaborators

VA New York Harbor Healthcare System
US federal agencylead

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveSleep Deprivation

Interventions

salicylhydroxamic acid

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic Manifestations

Study Officials

Miriam D Cohen
VA, NYHH
PRINCIPAL INVESTIGATOR

Enrollment

50 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: FED
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Nurse Practitioner

Study Record Dates

First Submitted

January 16, 2013

First Posted

January 21, 2013

Study Start

March 2009

Date type not reported

This date has not been verified as actual or estimated.

Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Nocturnal Air Purification

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (1)

Nocturnal Air Purification

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record